Susquehanna International Group
FBRX icon

Susquehanna International Group’s Forte Biosciences FBRX Stock Holding History

Susquehanna International Group’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$891K Buy
+34,400
New +$991K ﹤0.01% 8189
2022
Q1 		– Sell
-2,176
Closed -$116K – 13255
2021
Q4 		$116K Sell
2,176
-196
-8% -$13.2K ﹤0.01% 12028
2021
Q3 		$176K Buy
+2,372
New +$1.31M ﹤0.01% 11628
2020
Q3 		– Sell
-824
Closed -$300K – 10691
2020
Q2 		$300K Buy
824
+724
+724% +$324K ﹤0.01% 8366
2020
Q1 		$46K Buy
+100
New +$39.1K ﹤0.01% 9712
2019
Q4 		– Sell
-410
Closed -$102K – 9945
2019
Q3 		$102K Buy
410
+219
+115% +$332K ﹤0.01% 9547
2019
Q2 		$479K Buy
191
+70
+58% +$208K ﹤0.01% 7358
2019
Q1 		$495K Buy
121
+19
+19% +$73.4K ﹤0.01% 6299
2018
Q4 		$315K Buy
102
+28
+38% +$121K ﹤0.01% 6902
2018
Q3 		$435K Sell
74
-113
-60% -$430K ﹤0.01% 6792
2018
Q2 		$655K Buy
187
+76
+68% +$278K ﹤0.01% 6270
2018
Q1 		$493K Buy
111
+25
+29% +$116K ﹤0.01% 6665
2017
Q4 		$331K Buy
+86
New +$343K ﹤0.01% 7425

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Susquehanna International Group's FBRX Position: Q1 2026 in Review

Susquehanna International Group increased its Forte Biosciences (FBRX) stake by 152% in Q1 2026, buying an estimated $2.32M and bringing the position to 133,494 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #4977.

Susquehanna International Group first reported a position in FBRX in Q1 2018 and has held it in 17 quarters since. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Susquehanna International Group held 133,494 shares of Forte Biosciences worth $3.46M as of Q1 2026.
  • Susquehanna International Group bought 80,580 Forte Biosciences shares in Q1 2026, an estimated $2.32M.
  • Forte Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4977 holding.
  • Susquehanna International Group first reported a position in Forte Biosciences in Q1 2018 and has held it in 17 quarters since.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.